Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial

NCT06228079 is registered in ClinicalTrials.gov with Eye & ENT Hospital of Fudan University as lead sponsor.

NCT NCT06228079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06228079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial
Lead sponsor
Eye & ENT Hospital of Fudan University
Phase
Phase 3
Overall status
Recruiting
Start date
June 25, 2024
Completion date
June 30, 2028
Enrollment
176 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent nasopharyngeal carcinoma